Biotech

All Articles

' Clinical intuition' led FDA consultants to support Zevra's unusual health condition med

.Zevra Rehabs' rare illness medicine seems to be to be on the path to confirmation this loss after a...

Pfizer takes $230M struck after axing stopped working DMD genetics therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failure has actually gone a $230...

AC Immune views 'landmark' prospective in Alzheimer's medicine data

.After more than two decades of focus on neurodegenerative ailments, Swiss biotech air conditioning ...

GSK drops ph. 2 HPV vaccination over shortage of best-in-class potential

.GSK has actually scrapped a stage 2 individual papillomavirus (HPV) vaccination from its own pipeli...

OS Treatments refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will detail on the NYSE American sell substitution today by means of a $...

ALX's fizzling CD47 action cost delivers sell spiraling down

.ALX Oncology's stage 2 stomach cancer cells reaction cost has weakened. After seeing its CD47 block...

Ionis axes eye health condition from intendeds of Roche-partnered prospect after records disappoint

.Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of assumptions, motivating...

Biogen's chief executive officer mentioned no high-risk sell 2023. He's ready to become daring

.While Biogen's pharma peers are searching for late-stage resources along with little threat, chief ...

Instil refills pipe in $2B biobucks take care of ImmunOnco

.Instil Biography has been actually a biotech in search of a pipe after it scrapped its lead assets ...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored liberties to an early Alzheimer's illness course to Denali Therapies, ...